OTC : CMOPF

Cosmo Pharmaceuticals N.V.

$75.13 USD

-$1.97 (-2.56%)

Volume
15
Average Volume
297
Market Capitalization
$1.29B
P/E Ratio
-295.27
Dividend Yield
3.09%
Price Target
Year High
$169.90
Year Low
$64.37
Day High
—
Day Low
—
Payout Ratio
-$8.99
Current Ratio
$7.18
3333332"{? p/.m7yd f,0=

Annual earnings financials

CMOPF financial data with annual/quarterly toggle

CMOPF GAAP EPS - Annual & Quarterly

CMOPF Sales Revenue - Annual & Quarterly

CMOPF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CMOPF Estimated and Actual Revenue by Quarter
CMOPF Estimated and Actual EPS by Quarter
CMOPF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-06-30 1 7.1M 7.1M 7.1M 4.66M 4.66M 4.66M
2025-12-31 1 6.77M 6.77M 6.77M 4.44M 4.44M 4.44M
2025-06-30 1 16.61M 16.61M 16.61M 10.89M 10.89M 10.89M
2024-12-31 1 17.22M 17.22M 17.22M 11.3M 11.3M 11.3M
CMOPF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-06-30 1 - - - 1.88M 1.88M 1.88M
2025-12-31 1 - - - 1.79M 1.79M 1.79M
2025-06-30 1 - - - 4.4M 4.4M 4.4M
2024-12-31 1 - - - 4.56M 4.56M 4.56M
CMOPF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-06-30 1 22.36M 22.36M 22.36M 0 0 0 0
2025-12-31 1 21.31M 21.31M 21.31M 0 0 0 0
2025-06-30 1 52.3M 52.3M 52.3M 0 0 0 0
2024-12-31 1 54.24M 54.24M 54.24M 0 0 0 0